Published on
Last updated on
Webinar: Medical Device Pathways to Market for China
Webinar: Medical Device Pathways to Market for China
Various pathways are available to overseas manufacturers of medical devices and IVDs to register their products in China with the NMPA, but do you know which routes exist? What are their requirements? And do they even apply to the specific circumstances of your product?
Join us for our succinct 30-minute webinar designed to help you understand the options to choose the most appropriate pathway for your product market entry in China, the world's second-largest medical device market.
Webinar: Medical Device Pathways to Market for China Pathways covered:
- Standard NMPA Notifications & Registrations
- Hong Kong Listing
- Greater Bay Area Approvals
- Hainan Island Medical Tourism Zone Applications
- Innovative Medical Device / Green Route Applications
- Priority Registrations
- Emergency Registrations
Detailed information
Date: Thursday, February 15, 2924
Time: 14:00-14:30 CET / 08:00-08:30 ET
Presenter: Hamish King CEO & Anthony Barker
GET IN TOUCH
Related News
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.